Skip to Main Content

Author Details

Menashe Bar-Eli
The University of Texas MD Anderson Cancer Center
1975
207
71
PMIDPaper TitleJournal TitlePublished Year
34348992Gene Body Methylation of the Lymphocyte-Specific Gene <i>CARD11</i> Results in Its Overexpression and Regulates Cancer mTOR Signaling.Mol Cancer Res2021
33792569ATP11B mediates platinum resistance in ovarian cancer.J Clin Invest2021
32493919Author Correction: Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression.Nat Commun2020
31988194Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer.Gut2020
33344042MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanoma.Oncoimmunology2020
32725204Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit.JAMA Dermatol2020
31092620Editor's Note: Inhibition of Platelet-derived Growth Factor-mediated Proliferation of Osteosarcoma Cells by the Novel Tyrosine Kinase Inhibitor STI571.Clin Cancer Res2019
29386624A-to-I miR-378a-3p editing can prevent melanoma progression via regulation of PARVA expression.Nat Commun2018
29809169ATP11B mediates platinum resistance in ovarian cancer.J Clin Invest2018
29855470ADAR1-mediated regulation of melanoma invasion.Nat Commun2018
29959278Stress effects on FosB and interleukin-8 (<i>IL8</i>)-driven ovarian cancer growth and metastasis.J Biol Chem2018
28535802N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration.Genome Biol2017
28102366Aurora Kinase A is a Biomarker for Bladder Cancer Detection and Contributes to its Aggressive Behavior.Sci Rep2017
28855350Macrophages Facilitate Resistance to Anti-VEGF Therapy by Altered VEGFR Expression.Clin Cancer Res2017
26119932Targeting melanoma with NT157 by blocking Stat3 and IGF1R signaling.Oncogene2016
26272062Integrating Murine and Clinical Trials with Cabozantinib to Understand Roles of MET and VEGFR2 as Targets for Growth Inhibition of Prostate Cancer.Clin Cancer Res2016
27551498Mitochondrial oligomers boost glycolysis in cancer stem cells to facilitate blebbishield-mediated transformation after apoptosis.Cell Death Discov2016
27379162Protease-Activated Receptors and other G-Protein-Coupled Receptors: the Melanoma Connection.Front Genet2016
27041221A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer.Nat Commun2016
27013197NFAT1 Directly Regulates IL8 and MMP3 to Promote Melanoma Tumor Growth and Metastasis.Cancer Res2016
26819345Role of Increased n-acetylaspartate Levels in Cancer.J Natl Cancer Inst2016
26725326Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression.Oncogene2016
25046141The metastatic microenvironment: Claudin-1 suppresses the malignant phenotype of melanoma brain metastasis.Int J Cancer2015
25686251Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis.Nat Cell Biol2015
24106873Why is melanoma so metastatic?Pigment Cell Melanoma Res2014
25351346Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression.Nat Commun2014
24556724Monocyte subpopulations in angiogenesis.Cancer Res2014
23585472ATP11B mediates platinum resistance in ovarian cancer.J Clin Invest2013
23923820Crossing the junction in the gap of melanoma brain metastasis.Pigment Cell Melanoma Res2013
23651636Therapeutic destruction of insulin receptor substrates for cancer treatment.Cancer Res2013
23728176MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth.J Clin Invest2013
22643182Back to the embryonic stage: Nodal as a biomarker for breast cancer progression.Breast Cancer Res2012
22986745Galectin-3 contributes to melanoma growth and metastasis via regulation of NFAT1 and autotaxin.Cancer Res2012
22684365Driving transcriptional regulators in melanoma metastasis.Cancer Metastasis Rev2012
22465753Lysophosphatidic acid induces lymphangiogenesis and IL-8 production in vitro in human lymphatic endothelial cells.Am J Pathol2012
22672152The sweet and bitter sides of galectins in melanoma progression.Pigment Cell Melanoma Res2012
21187389Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype.Proc Natl Acad Sci U S A2011
22009534PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis.Cancer Res2011
21593728Searching for the 'melano-miRs': miR-214 drives melanoma metastasis.EMBO J2011
21738104A phase II study of gefitinib in patients with metastatic melanoma.Melanoma Res2011
21378407The emerging role of the thrombin receptor (PAR-1) in melanoma metastasis--a possible therapeutic target.Oncotarget2011
21358280Chitosan hydrogel for localized gene silencing.Cancer Biol Ther2011
21467165Expression of Id-1 is regulated by MCAM/MUC18: a missing link in melanoma progression.Cancer Res2011
21147226Transcriptional control of melanoma metastasis: the importance of the tumor microenvironment.Semin Cancer Biol2011
21168861Receptor heterodimerization: a new mechanism for platelet-derived growth factor induced resistance to anti-epidermal growth factor receptor therapy for bladder cancer.J Urol2011
20179193The dicey role of Dicer: implications for RNAi therapy.Cancer Res2010
20805990CREB inhibits AP-2alpha expression to regulate the malignant phenotype of melanoma.PLoS One2010
20826776Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis.J Biol Chem2010
20824051Reactive astrocytes protect melanoma cells from chemotherapy by sequestering intracellular calcium through gap junction communication channels.Neoplasia2010
20973929Estela Medrano, 1943-2010.Pigment Cell Melanoma Res2010
  • 1 - 50 of 207

Recommended Authors

Manoela Tiago
Thomas Jefferson University
Career Start Year 2011
Number of shared co-authors 2
Mitchell P Levesque
University Hospital Zurich
Career Start Year 2009
Number of shared co-authors 4
Phil F Cheng
University Hospital of Zurich
Career Start Year 2007
Number of shared co-authors 6
Michael P O'Connell
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 1
Vijay Walia
National Center for Toxicological Research
Career Start Year 2006
Number of shared co-authors 2
Harriet M Kluger
Yale School of Medicine
Career Start Year 2003
Number of shared co-authors 7
Chi-Ping Day
Center for Cancer Research, National Cancer Institute
Career Start Year 2002
Number of shared co-authors 6
Fr??d??rique Deshayes
Universite Paris Cite, CNRS
Career Start Year 2002
Number of shared co-authors 1
Daniela Mihic-Probst
University Hospital Zurich
Career Start Year 2001
Number of shared co-authors 2
Mairin Rafferty
Oncomark Ltd.
Career Start Year 2001
Number of shared co-authors 1
Daniel Zingg
Netherlands Cancer Institute
Career Start Year 2001
Number of shared co-authors 1
Yardena Samuels
Weizmann Institute of Science
Career Start Year 1998
Number of shared co-authors 6
Cindy Sander
UPMC Hillman Cancer Center
Career Start Year 1997
Number of shared co-authors 4
Roya Navab
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1997
Number of shared co-authors 2
Andrew E Aplin
Thomas Jefferson University
Career Start Year 1996
Number of shared co-authors 9
Jan Paul Medema
Oncode Institute
Career Start Year 1993
Number of shared co-authors 4
Ashani T Weeraratna
Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine
Career Start Year 1992
Number of shared co-authors 9
Wan-Hee Yoon
Oklahoma Medical Research Foundation
Career Start Year 1992
Number of shared co-authors 0
Marcus Bosenberg
Yale School of Medicine
Career Start Year 1992
Number of shared co-authors 12
Rosalba Salcedo
Center for Cancer Research, National Cancer Institute
Career Start Year 1990
Number of shared co-authors 0
Roger Chammas
Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina de Sao Paulo
Career Start Year 1989
Number of shared co-authors 1
Daniel S Peeper
Netherlands Cancer Institute
Career Start Year 1987
Number of shared co-authors 4
Fredika M Robertson
University of Texas M.D. Anderson Cancer Center
Career Start Year 1987
Number of shared co-authors 0
Grant A McArthur
University of Melbourne
Career Start Year 1986
Number of shared co-authors 8
Jonathan Cebon
Australia Olivia Newton-John Cancer Research Institute, La Trobe University
Career Start Year 1985
Number of shared co-authors 2
Erwin G Van Meir
Heersink School of Medicine, University of Alabama at Birmingham
Career Start Year 1984
Number of shared co-authors 7
David E Fisher
Cutaneous Biology Research Center, Mass. General Hospital, Harvard Medical School
Career Start Year 1983
Number of shared co-authors 12
Adrian L Harris
University of Oxford
Career Start Year 1981
Number of shared co-authors 11
Fabien Calvo
Universite de Paris-Cite
Career Start Year 1979
Number of shared co-authors 0
Glenn Merlino
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1978
Number of shared co-authors 10

Collaborators

David J McConkey
Johns Hopkins School of Medicine
Co-authored papers 23
Anil K Sood
The University of Texas MD Anderson Cancer Center
Co-authored papers 21
Gabriel J Villares
University of St. Thomas
Co-authored papers 18
Colin P Dinney
The University of Texas MD Anderson Cancer Center
Co-authored papers 17
Suyun Huang
Virginia Commonwealth University
Co-authored papers 17
Cristina Ivan
The University of Texas MD Anderson Cancer Center
Co-authored papers 14
Jeffrey E Gershenwald
The University of Texas MD Anderson Cancer Center
Co-authored papers 12
Liana Adam
The University of Texas MD Anderson Cancer Center
Co-authored papers 11
Rajesha Rupaimoole
Harvard Medical School, Beth Israel Deaconess Medical Center
Co-authored papers 9
Keith A Baggerly
The University of Texas MD Anderson Cancer Center
Co-authored papers 7
Bogdan Czerniak
University of Texas MD Anderson Cancer Center
Co-authored papers 7
Chad V Pecot
University of North Carolina at Chapel Hill
Co-authored papers 5
Keping Xie
The South China University of Technology Comprehensive Cancer Center
Co-authored papers 5
Mary Territo
Co-authored papers 5
Jolanta Bondaruk
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Herbert Barton Grossman
University of Texas MD Anderson Cancer Center
Co-authored papers 4
Rosemarie Schmandt
The University of Texas MD Anderson Cancer Center, UT MD Anderson Cancer Center
Co-authored papers 4
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 3
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
Amy B Heimberger
Northwestern University Feinberg School of Medicine
Co-authored papers 3
Kelly N Blehm
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 3
Wei Zhang
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
Ze'ev Ronai
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 3
Yi-Jue Zhao
The First Affiliated Hospital of Guangxi Medical University
Co-authored papers 3
Fernando Rodrigues-Lima
Universite Paris Cite, CNRS
Co-authored papers 2
Steven J M Jones
University of British Columbia
Co-authored papers 2
Kenneth Aldape
National Cancer Institute
Co-authored papers 2
Mircea Ivan
Indiana University School of Medicine
Co-authored papers 2
Steven E Scherer
Baylor College of Medicine
Co-authored papers 2
Amy G Robertson
Present address: Dxige Research Inc.
Co-authored papers 2
Release 1.2